| Target Price | $61.20 |
| Price | $58.84 |
| Potential |
4.01%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target Bruker Corporation 2027 .
The average Bruker Corporation target price is $61.20.
This is
4.01%
register free of charge
$73.50
24.92%
register free of charge
$40.40
31.34%
register free of charge
|
|
| A rating was issued by 21 analysts: 13 Analysts recommend Bruker Corporation to buy, 7 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Bruker Corporation stock has an average upside potential 2027 of
4.01%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.44 | 3.63 |
| 2.08% | 5.57% | |
| EBITDA Margin | 14.37% | 18.34% |
| 15.25% | 27.63% | |
| Net Margin | -0.65% | 9.09% |
| 119.49% | 1,488.35% |
17 Analysts have issued a sales forecast Bruker Corporation 2026 . The average Bruker Corporation sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Bruker Corporation EBITDA forecast 2026. The average Bruker Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 Bruker Corporation Analysts have issued a net profit forecast 2026. The average Bruker Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.15 | 2.16 |
| 119.74% | 1,540.00% | |
| P/E | 26.76 | |
| EV/Sales | 2.88 |
17 Analysts have issued a Bruker Corporation forecast for earnings per share. The average Bruker Corporation EPS is
This results in the following potential growth metrics and future valuations:
Bruker Corporation...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Guggenheim |
Locked
➜
Locked
|
Locked | Oct 01 2026 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Sep 29 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Jul 08 2026 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Jul 07 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Jun 29 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Guggenheim:
Locked
➜
Locked
|
Oct 01 2026 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Sep 29 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Jul 08 2026 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Jul 07 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Jun 29 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


